Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose for this study is to find out if Thought field therapy has the same effect as, or better effect than, Cognitive therapy for Agoraphobia.
Thought field therapy is an alternative treatment method that has shown, by casuistic reports, to give good results when applied for anxiety disorders. In this study 72 patients will be randomized to three groups. 24 patients will receive cognitive therapy as a control method, 24 patients will receive thought field therapy. The remaining 24 patients will wait three months, and then be randomized to either of the two therapies.
Before inclusion all patients will be diagnosed with M.I.N.I. and SCID II. They will fill out self evaluation forms for symptoms and quality of life, before and after treatment, and one year after treatment.
All patients will undergo an interview with ADIS on panic and agoraphobic diagnosis and symptoms before starting treatment, and on panic and agoraphobic symptoms immediately after and one year after treatment. These interviews will be done by psychologists who are blinded for which type of treatment the patients have got.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Thought field therapy | Experimental | 24 randomly selected patients will be treated with 5 sessions of standard Thought field therapy. |
|
| Cognitive therapy | Active Comparator | Treatment with Cognitive therapy, 12 sessions with manualized therapy according to David Clark's model. |
|
| Wait list | Other | 24 patients will be randomly selected to 3 months on a wait list, thereafter randomly selected to either Cognitive therapy or Thought field therapy. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Thought field therapy | Behavioral | 5 sessions with Thought field therapy |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in agoraphobic situation scores in ADIS. | Immedeately and 12 months after treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Interference score in ADIS | Immediately and 12 months after treatment | |
| Mobility Inventory | Immediately and 12 months after treatment | |
| Agoraphobic Cognitions Questionnaire |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Audun C Irgens, MD | Sorlandet Hospital HF, Norway | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sorlandet Hospital | Arendal | 4809 | Norway |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 28676782 | Derived | Irgens AC, Hoffart A, Nysaeter TE, Haaland VO, Borge FM, Pripp AH, Martinsen EW, Dammen T. Thought Field Therapy Compared to Cognitive Behavioral Therapy and Wait-List for Agoraphobia: A Randomized, Controlled Study with a 12-Month Follow-up. Front Psychol. 2017 Jun 20;8:1027. doi: 10.3389/fpsyg.2017.01027. eCollection 2017. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000379 | Agoraphobia |
| ID | Term |
|---|---|
| D010698 | Phobic Disorders |
| D001008 | Anxiety Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D015928 | Cognitive Behavioral Therapy |
| D014850 | Waiting Lists |
| ID | Term |
|---|---|
| D001521 | Behavior Therapy |
| D011613 | Psychotherapy |
| D004191 | Behavioral Disciplines and Activities |
| D001071 | Appointments and Schedules |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Cognitive therapy | Behavioral | 12 sessions of Cognitive therapy |
|
|
| Wait list | Behavioral | 3 months waiting, then randomized to either thought field therapy or cognitive therapy |
|
|
| Immediately and 12 months after treatment |
| Body Sensations Questionnaire | Immediately and 12 months after treatment |
| BDI | Immediately and 12 months after treatment |
| BAI | Immediately and 12 months after treatment |
| WHOQOL-BREF | Immediately and 12 months after treatment |
| SF-36 | Immediately and 12 months after treatment |
| Safety Seeking Behaviours Questionnaire. | Immediately and 12 months after treatment |
| Panic scale | Immediately and 12 months after treatment |
| D009934 | Organization and Administration |
| D006298 | Health Services Administration |